Advanced search

A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer

(2005) INVESTIGATIONAL NEW DRUGS. 23(1). p.85-89
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
CAPONIGRO, F, P WILLEMSE, R SORIO, A FLOQUET, Simon Van Belle, J DEMOL, R TAMBARO, et al. 2005. “A Phase II Study of Sabarubicin (MEN-10755) as Second Line Therapy in Patients with Locally Advanced or Metastatic Platinum/taxane Resistant Ovarian Cancer.” Investigational New Drugs 23 (1): 85–89.
APA
CAPONIGRO, F., WILLEMSE, P., SORIO, R., FLOQUET, A., Van Belle, S., DEMOL, J., TAMBARO, R., et al. (2005). A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer. INVESTIGATIONAL NEW DRUGS, 23(1), 85–89.
Vancouver
1.
CAPONIGRO F, WILLEMSE P, SORIO R, FLOQUET A, Van Belle S, DEMOL J, et al. A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer. INVESTIGATIONAL NEW DRUGS. KLUWER ACADEMIC PUBL; 2005;23(1):85–9.
MLA
CAPONIGRO, F, P WILLEMSE, R SORIO, et al. “A Phase II Study of Sabarubicin (MEN-10755) as Second Line Therapy in Patients with Locally Advanced or Metastatic Platinum/taxane Resistant Ovarian Cancer.” INVESTIGATIONAL NEW DRUGS 23.1 (2005): 85–89. Print.
@article{342061,
  author       = {CAPONIGRO, F and WILLEMSE, P and SORIO, R and FLOQUET, A and Van Belle, Simon and DEMOL, J and TAMBARO, R and COMANDINI, A and CAPRIATI, A and ADANK, S and WANDERS, J},
  issn         = {0167-6997},
  journal      = {INVESTIGATIONAL NEW DRUGS},
  language     = {eng},
  number       = {1},
  pages        = {85--89},
  publisher    = {KLUWER ACADEMIC PUBL},
  title        = {A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer},
  volume       = {23},
  year         = {2005},
}

Web of Science
Times cited: